Additionally, approximately one-third of depressed patients exhibited low-grade inflammatory status (i.e., CRP > 3.0 mg/L), suggesting the presence of a different subgroup of Major Depressive Disorder (MDD) with distinct etiopathogenesis, and prognosis, which could potentially respond to anti-inflammatory treatments [57,58]. Here, CRP is linked to major depressive disorder.